EpimAb Biotherapeutics Raises $25M In Series A Financing From International Consortium To Advance Pipeline Of Novel Bispecific Antibodies Post author:Sam Post published:April 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic December 12, 2017 Reunited and It Feels So Good: After the Success of Serial Biotech Duo Launches February 8, 2017 3 Marijuana Biotech Stock Winners for 2018 December 21, 2017
Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic December 12, 2017